PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Apr-2022 Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Sanofi
28-Apr-2022 Solvay and Carbios demonstrate enzymatic depolymerization in PET/PVDC barrier film Solvay and Carbios
28-Apr-2022 Immutep to announce new TACTI-002 data in an oral presentation at the ASCO 2022 Annual Meeting Immutep Limited
28-Apr-2022 OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases OMass Therapeutics
28-Apr-2022 EVERSANA™ and Vector Pharma FZCO Announce Strategic Partnership to Expand Commercialisation Services Throughout Middle East and North Africa EVERSANA
28-Apr-2022 Copley launches a new semi-automation tool for inhaled product testing Copley Scientific
28-Apr-2022 Thermo Fisher Scientific Expands State-of-the-art R&D Facility in Hyderabad Thermo Fisher Scientific
28-Apr-2022 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update CureVac
28-Apr-2022 Asklepios Kliniken: Stable development in 2021 financial year despite negative impact from COVID-19 pandemic Asklepios Kliniken
28-Apr-2022 Skin Analytics Receives Class IIA UKCA Mark for AI-based Skin Cancer Tool that Supports Dermatology Capacity in the NHS Skin Analytics
28-Apr-2022 Syncona invests in £75.5 million Series B financing of OMass Therapeutics Syncona Ltd
28-Apr-2022 Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients Vifor Fresenius Medical Care Renal Pharma
28-Apr-2022 Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meeting SOTIO Biotech
28-Apr-2022 MGI Launches HotMPS High-throughput Sequencing Kit* MGI
28-Apr-2022 New BHM® Anti-Viral Nasal Spray launches in Singapore Sciad Newswire
28-Apr-2022 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2022 Heidelberg Pharma AG
28-Apr-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Full Year 2021 Financial Results and Highlights Operational Progress (news with additional features) Vivoryon Therapeutics N.V.
28-Apr-2022 Straumann Group reports very strong first quarter Straumann Holding AG
27-Apr-2022 PAION GRANTS EXCLUSIVE LICENSE TO CRISTÁLIA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN LATIN AMERICA PAION AG
27-Apr-2022 Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meeting B3C newswire